Abstract

The present study describes the development and validation of two simple, sensitive, accurate, precise and economical spectrophotometric methods for the estimation of Etravirine (ETR) in bulk and its tablet dosage forms. These methods have developed based on the diazotization of ETR followed by coupling with alkaline β-naphthol (Method-A) and p-nitro aniline in alkaline medium (Method-B). These methods show a linear relation between absorbance and concentration of ETR in the ranges of 5 - 30 μg/mL (MA) and 2.5 - 15 μg/mL(M-B) respectively. The Molar absorptive for present methods are 3.685 x 103 (M-A) and 5.614 x 104 (M-B) and LOD, LOQ values are 0.656 μg/mL, 1.990 μg/mL (M-A) and 0.191 μg/mL, 0.578 μg/mL (M-B) respectively. The common excipients in the drug did not interfere in the estimation process and the developed methods are successfully applied to tablet dosage forms of ETR.

Keywords: Etravirine; β-Naphthol; p-Nitro Aniline; Alkaline Medium; Spectrophotometry

References

1. Berma HM., et al. “The Protein Data Bank”. Nucleic Acids Research1 (2000): 235-242.
2. Satyanarayana L., et al. “The estimation of etravirine in tablet dosage form by RP-HPLC”. Asian Journal of Research in Chemistry10 (2011): 1649-1651.
3. Chinnalalaiah R and Kumar RP. “Development and validation of a new RP-HPLC method for estimation of etravirine in bulk and pharmaceutical dosage form”. International Journal of Pharma Sciences 4 (2013): 291-294.
4. Babu GR., et al. “Development and validation of RP-HPLC method for quantitative analysis of etravirine in pure and pharmaceutical formulations”. International Journal of Pharmacy4 (2013): 747-752.
5. Murali D and Rambabu C. “Development and validation of stability indicating RP-HPLC method for the quantification of Etravirine in tablet dosage form”. Der Pharmacia Lettre12 (2015): 216-226.
6. Thangabhalan B., et al. “Stability indicating RP–HPLC method for the estimation of etravirine in pure and tablet dosage form”. International Journal of Pharmamedix India4 (2013): 581-591.
7. D’Avolio A., et al. “HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions”. Journal of Pharmaceutical and Biomedical Analysis5 (2010): 774-780.
8. Else L., et al. “Validation of a rapid and sensitive high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay for the simultaneous determination of existing and new antiretroviral compounds”. Journal of Chromatography B19 (2010): 1455-1465.
9. Raja AP and Venkateshwar RJ. “HPTLC method development and validation for determination of etravirine in bulk and tablet dosage form”. International Journal of Pharmacy and Biological Sciences3 (2013): 515-522.
10. Abobo CV., et al. “LC-MS/MS determination of etravirine in rat plasma and its application in pharmacokinetic studies”. Journal of Chromatography B30 (2010): 3181-3186.
11. Rezk NZ., et al. “A novel LC-ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma”. Talanta 5 (2009):1372-1378.
12. Fayet A., et al. “A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir and Etravirine”. Journal of Chromatography B11-12 (2009): 1057-1069.
13. Heine R., et al. ‘Quantification of Etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry”. Journal of Pharmaceutical and Biomedical Analysis 2 (2009): 393-400.
14. Reddy CM and Reddy KH. “A novel validated stability indicative UPLC method for Etravirine for the determination of process related and degradation impurities”. American Journal of Analytical Chemistry12 (2012): 840-848.
15. Aleem A. “Development and validation of stability indicating ultra performance liquid chromatographic method for Etravirine”. International Journal of Pharmacy and Pharmaceutical Sciences1 (2012): 255-261.
16. Djerada Z., et al. “Validation of a fast method for quantitative analysis of elvitegravir, raltegravir, maraviroc, etravirine, tenofovir, boceprevir and 10 other antiretroviral agents in human plasma samples with a new UPLC-MS/MS technology”. Journal of Pharmaceutical and Biomedical Analysis 86 (2013): 100-111.
17. Reddaiah CV., et al. “Estimation of Etravirine by UV-Visible spectroscopic method in tablet dosage form and it’s In vitro dissolution assessment”. International Journal of Pharmacy Research and Development3 (2012): 287-295.
18. Murali D., et al. “Spectrophotometric Determination of Etravirine in Bulk and Pharmaceutical formulations”. American Journal of Analytical Chemistry 5 (2014): 77-82.
19. Ameera H Hamed. “Simple Method for Spectrophotometric Determination of Benzidine in Aqueous Solutions by Coupling with β-Naphthol”. Journal of Al-Nahrain University 2 (2011): 43-50.
20. Nabeel S Othman and Nabil H Othman. “Spectrophotometric Determination of Teicoplanin via Coupling with Diazotized p-Nitro aniline”. Rafidian Journal of Science5 (2013): 42-51.

Citation

Citation: Murali Dadi., et al. “Development and Validation of Visible Spectrophotometric Methods for the Analysis of Etravirine: Application to Tablet Dosage Forms".Acta Scientific Pharmaceutical Sciences 4.6 (2020): 15-19.

Copyright

Copyright: © 2020 Murali Dadi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.